It’s important to determine whether stroke patients also experience atrial fibrillation (Afib).

A new paper identifies strategies that providers might use to help their patients better balance the risks and benefits of anticoagulants.

A new study finds patients were taking too many antithrombotics for no reason, leading to a significant increase in bleeding events.

Anticoagulant therapy is important for stroke prevention in people with atrial fibrillation, but a new study shows many people don’t stick with it.

For Afib patients, lowering the risk of stroke is crucial. A late-breaking trial presented at AHA Scientific Sessions compares anti-thrombotic agents when coronary disease is also a factor.